Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells
NCT ID: NCT01062750
Last Updated: 2015-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4 participants
INTERVENTIONAL
2012-10-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells
NCT00913289
Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis
NCT03209986
Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis
NCT02705742
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01220492
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
NCT02297867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adipose tissue derived stromal cells
adipose tissue derived stromal cells dosage
single administration of autologous adipose tissue derived stroma cells via intrahepatic arterial catheterization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
adipose tissue derived stromal cells dosage
single administration of autologous adipose tissue derived stroma cells via intrahepatic arterial catheterization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanazawa University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shuichi Kaneko
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shuichi Kaneko, M.D.
Role: STUDY_CHAIR
Kanazawa University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.